{"entity":{"type":"insider","cik":"0001802687","url":"/insider/0001802687","json_url":"/insider/0001802687.json","name":"Sims Andrew John Hugh MacIntyre","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2021-07-29","last":"2025-11-05","span_basis":"filed_date"},"name_variants":[{"name":"Sims Andrew John Hugh MacIntyre","source":"filing","n_filings":8,"first_seen":"2021-07-29","last_seen":"2025-11-05"}],"transactions":[{"id":4795940,"accession":"0001193125-25-265866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-265866","line_url":"/filing/0001193125-25-265866#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":10200.0,"total_display":"10,200.00","total_whole":"10,200","shares_owned_after":68138.0,"shares_owned_after_display":"68,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-04","filed_date":"2025-11-05","scope":"insider"},{"id":2550643,"accession":"0000950170-24-105330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-105330","line_url":"/filing/0000950170-24-105330#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4098.0,"shares_display":"4,098","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":5204.46,"total_display":"5,204.46","total_whole":"5,204","shares_owned_after":9815.0,"shares_owned_after_display":"9,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-11","scope":"insider"},{"id":2205011,"accession":"0000950170-24-057456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-057456","line_url":"/filing/0000950170-24-057456#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4902.0,"shares_display":"4,902","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":10000.08,"total_display":"10,000.08","total_whole":"10,000","shares_owned_after":5717.0,"shares_owned_after_display":"5,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-10","scope":"insider"},{"id":6098142,"accession":"0001209191-22-025719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025719","line_url":"/filing/0001209191-22-025719#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.672,"price_display":"0.67","price_state":"stated","total_value":2016.0,"total_display":"2,016.00","total_whole":"2,016","shares_owned_after":12230.0,"shares_owned_after_display":"12,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-26","filed_date":"2022-04-27","scope":"insider"},{"id":6566054,"accession":"0001209191-22-015201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-015201","line_url":"/filing/0001209191-22-015201#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.0999,"price_display":"1.10","price_state":"stated","total_value":2199.8,"total_display":"2,199.80","total_whole":"2,200","shares_owned_after":9230.0,"shares_owned_after_display":"9,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider"},{"id":4343740,"accession":"0001209191-21-062868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-062868","line_url":"/filing/0001209191-21-062868#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.8643,"price_display":"1.86","price_state":"stated","total_value":1864.3,"total_display":"1,864.30","total_whole":"1,864","shares_owned_after":7230.0,"shares_owned_after_display":"7,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-04","scope":"insider"},{"id":5500530,"accession":"0001209191-21-061723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-061723","line_url":"/filing/0001209191-21-061723#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.6694,"price_display":"1.67","price_state":"stated","total_value":3338.8,"total_display":"3,338.80","total_whole":"3,339","shares_owned_after":6230.0,"shares_owned_after_display":"6,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-27","scope":"insider"},{"id":5381366,"accession":"0001209191-21-048660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-048660","line_url":"/filing/0001209191-21-048660#line-2","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2244.0,"shares_display":"2,244","price_per_share":1.9099,"price_display":"1.91","price_state":"stated","total_value":4285.8156,"total_display":"4,285.82","total_whole":"4,286","shares_owned_after":4230.0,"shares_owned_after_display":"4,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-29","scope":"insider"},{"id":5381365,"accession":"0001209191-21-048660","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048660","line_url":"/filing/0001209191-21-048660#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001802687","owner_name":"Sims Andrew John Hugh MacIntyre","owner_display_name":"Sims Andrew John Hugh MacIntyre","owner_url":"/insider/0001802687","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1986.0,"shares_display":"1,986","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":4071.3,"total_display":"4,071.30","total_whole":"4,071","shares_owned_after":1986.0,"shares_owned_after_display":"1,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-27","filed_date":"2021-07-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001095981","name":"PLUS THERAPEUTICS, INC.","url":"/issuer/0001095981","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2021-07-29","last_seen":"2025-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001802687","retrieved_at":"2026-08-26T01:57:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}